Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

21 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
The impact of timing of temozolomide chemoradiotherapy for newly diagnosed glioblastoma on patient overall survival: A multicenter retrospective study.
Lau ACK, Chan BLH, Yeung CSK, Li LF, Chan DTM, Lee MWY, Chan TKT, Ho JMK, Cheung KM, Tse TPK, Lau SSN, Chow JSW, Ko NMW, Loong HHF, El-Helali A, Poon WS, Woo PYM. Lau ACK, et al. Among authors: el helali a. Neurooncol Adv. 2024 Nov 12;6(1):vdae194. doi: 10.1093/noajnl/vdae194. eCollection 2024 Jan-Dec. Neurooncol Adv. 2024. PMID: 39659837 Free PMC article.
First-in-human study of AMG 193, an MTA-cooperative PRMT5 inhibitor, in patients with MTAP-deleted solid tumors: results from phase I dose exploration.
Rodon J, Prenen H, Sacher A, Villalona-Calero M, Penel N, El Helali A, Rottey S, Yamamoto N, Ghiringhelli F, Goebeler ME, Doi T, Postel-Vinay S, Lin CC, Liu C, Chuang CH, Keyvanjah K, Eggert T, O'Neil BH. Rodon J, et al. Among authors: el helali a. Ann Oncol. 2024 Dec;35(12):1138-1147. doi: 10.1016/j.annonc.2024.08.2339. Epub 2024 Sep 16. Ann Oncol. 2024. PMID: 39293516 Clinical Trial.
Direct oral anticoagulants versus low-molecular-weight heparin in patients with cancer-associated venous thrombosis: a cost-effectiveness analysis.
Kang W, Peng K, Yan VKC, Al-Badriyeh D, Lee SF, Yiu HHE, Wei Y, Li STH, Ye X, El Helali A, Lam KO, Lee VHF, Wong ICK, Chan EW. Kang W, et al. Among authors: el helali a. J Pharm Policy Pract. 2024 Jul 17;17(1):2375269. doi: 10.1080/20523211.2024.2375269. eCollection 2024. J Pharm Policy Pract. 2024. PMID: 39027009 Free PMC article.
Effectiveness and safety of continuous low-molecular-weight heparin versus switching to direct oral anticoagulants in cancer-associated venous thrombosis.
Kang W, Huang C, Yan VKC, Wei Y, Shami JJP, Li STH, Yang Y, Ye X, Tang J, Lee SF, Lee VHF, Chan SL, El Helali A, Lam KO, Ngan RKC, Wong ICK, Chan EW. Kang W, et al. Among authors: el helali a. Nat Commun. 2024 Jul 5;15(1):5657. doi: 10.1038/s41467-024-50037-1. Nat Commun. 2024. PMID: 38969649 Free PMC article.
Efficacy, safety, and correlative biomarkers of bintrafusp alfa in recurrent or metastatic nasopharyngeal cancer patients: a phase II clinical trial.
Chiang CL, Lam TC, Li JCB, Chan KSK, El Helali A, Lee YYP, Law LHT, Zheng D, Lo AWI, Kam NW, Li WS, Cheung AKW, Chow JCH, Chan SPC, Lai JWY, Lee SWM, Kong FS, Ng WT, Kwong DLW, Lee AWM. Chiang CL, et al. Among authors: el helali a. Lancet Reg Health West Pac. 2023 Sep 6;40:100898. doi: 10.1016/j.lanwpc.2023.100898. eCollection 2023 Nov. Lancet Reg Health West Pac. 2023. PMID: 37701718 Free PMC article.
The impact of the multi-disciplinary molecular tumour board and integrative next generation sequencing on clinical outcomes in advanced solid tumours.
El Helali A, Lam TC, Ko EY, Shih DJH, Chan CK, Wong CHL, Wong JWH, Cheung LWT, Lau JKS, Liu APY, Chan ASY, Loong HH, Lam STS, Chan GC, Lee VHF, Yuen KK, Ng WT, Lee AWM, Ma ESK. El Helali A, et al. Lancet Reg Health West Pac. 2023 Apr 28;36:100775. doi: 10.1016/j.lanwpc.2023.100775. eCollection 2023 Jul. Lancet Reg Health West Pac. 2023. PMID: 37547050 Free PMC article.
21 results